News >

Mesothelin-Targeted CAR T Cells Show Early Promise in Solid Tumors

Caroline Seymour
Published: Friday, Apr 12, 2019

Prasad S. Adusumilli, MD

Prasad S. Adusumilli, MD
The antitumor activity and tolerability with mesothelin-targeted CAR T-cell therapy in malignant pleural disease from mesothelioma has generated optimism for the approach in solid tumors, according to Prasad S. Adusumilli, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication